Improving the quality of cancer clinical trials workshop summary /

Improving the quality of cancer clinical trials workshop summary /

Show other versions (1)
Saved in:
Bibliographic Details
Corporate Authors: National Cancer Policy Forum (U.S.), Institute of Medicine (U.S.), ebrary, Inc
Other Authors: Patlak, Margie, Nass, Sharyl J.
Format: Electronic eBook
Language:English
Published: Washington, D.C. : National Academies Press, c2008.
Subjects:
Cancer > Treatment > United States.
Clinical trials.
Electronic books.
Online Access:An electronic book accessible through the World Wide Web; click to view
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000nam a2200000 a 4500
001 0000101425
005 20171002055247.0
006 m u
007 cr cn|||||||||
008 080709s2008 dcua sb 000 0 eng d
010 |z  2008299448 
020 |z 9780309116688 
020 |z 0309116686 
035 |a (CaPaEBR)ebr10235163 
035 |a (OCoLC)560530759 
040 |a CaPaEBR  |c CaPaEBR 
043 |a n-us--- 
050 1 4 |a RC270.8  |b .I47 2008eb 
082 0 4 |a 362.196/994007  |2 22 
245 0 0 |a Improving the quality of cancer clinical trials  |h [electronic resource] :  |b workshop summary /  |c National Cancer Policy Forum, Margie Patlack and Sharyl Nass, rapporteurs. 
260 |a Washington, D.C. :  |b National Academies Press,  |c c2008. 
300 |a xii, 124 p. :  |b ill. (some col.). 
504 |a Includes bibliographical references. 
505 0 |a Introduction -- New clinical trial designs. Phase 0 trials -- Adaptive trial designs -- Targeting multiple pathways with multiple drugs -- Preclinical model systems -- Molecular imaging. Current and developing methods -- Challenges of molecular imaging -- Screening for predictive markers. The challenges of clinical validation -- Bioimaging predictive markers -- Clinical translation -- Panel discussion -- Costs of clinical trials. Regulatory costs -- Patient accrual -- Global outsourcing -- Time is money -- Public-private collaborations -- Regulatory issues. Regulatory barriers to innovation -- Patient advocacy perspective -- Regulation of in vitro diagnostics -- Regulatory issues in improving cancer clinical trials -- Reports from the case study discussion groups. Adaptive trial design -- Phase 0 trials -- Imaging -- Use of proteomics/genomics to assign therapy in lung cancer -- Use of genetics/genomics to assign therapy. 
530 |a Also available on the World Wide Web. 
533 |a Electronic reproduction.  |b Palo Alto, Calif. :  |c ebrary,  |d 2013.  |n Available via World Wide Web.  |n Access may be limited to ebrary affiliated libraries. 
650 0 |a Cancer  |x Treatment  |z United States. 
650 0 |a Clinical trials. 
655 7 |a Electronic books.  |2 local 
700 1 |a Patlak, Margie. 
700 1 |a Nass, Sharyl J. 
710 2 |a National Cancer Policy Forum (U.S.) 
710 2 |a Institute of Medicine (U.S.) 
710 2 |a ebrary, Inc. 
856 4 0 |u http://site.ebrary.com/lib/daystar/Doc?id=10235163  |z An electronic book accessible through the World Wide Web; click to view 
908 |a 170314 
942 0 0 |c EB 
999 |c 90578  |d 90578 

Similar Items